T helper cells subtypes and their cytokine gene expression affected by carvacrol in sensitized mice administered during sensitization period.
Animals
Asthma
/ drug therapy
Cymenes
/ pharmacology
Cytokines
/ genetics
Dexamethasone
/ pharmacology
Gene Expression
Gene Expression Regulation
/ drug effects
Humans
Interferon-gamma
/ genetics
Interleukin-17
/ genetics
Interleukin-4
/ genetics
Mice
Ovalbumin
/ genetics
T-Lymphocytes, Regulatory
/ drug effects
Th1 Cells
/ immunology
Th17 Cells
/ immunology
Th2 Cells
/ immunology
Transforming Growth Factor beta
/ genetics
animal model
asthma
carvacrol
cytokines
flow cytometry
Journal
Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
13
07
2018
accepted:
12
09
2018
pubmed:
6
11
2018
medline:
14
7
2020
entrez:
3
11
2018
Statut:
ppublish
Résumé
Th1, Th2, Th17, and Treg cells and their cytokine gene expressions in splenocytes of control mice, ovalbumin sensitized (S), and S treated with dexamethasone and carvacrol during a sensitization period were examined. Th2 and Th17 population as well as the gene expression of IL-4, IL-17, and TGF-β were increased, but Th1, Th1/Th2 ratio, the gene expression of IFN-γ and FOXP3 as well as the IFN-γ/IL-4 ratio were decreased in S compared with control group ( P < 0.001 for all cases). Carvacrol treatment caused significant reduction of Th2 and Th17 population as well as gene expression of IL-4, IL-17, and TGF-β but increase in Treg cells, Th1/Th2 ratio, gene expressions of FOXP3, IFN-γ, and IFN-γ/IL-4 ratio ( P < 0.05 to P < 0.001). The population of Th1, Th2, Th17 cells as well as the gene expression of IL-4, IL-17, and TGF-β were significantly decreased, but only Treg was increased in the dexamethasone treatment group ( P < 0.05 to P < 0.001). Carvacrol treatment during the sensitization period showed a more specific effect on Th1/Th2 imbalance in sensitized mice than dexamethasone, which may indicate the therapeutic potentials of carvacrol in disorders associated with Th1/Th2 imbalance such as asthma.
Substances chimiques
Cymenes
0
Cytokines
0
IFNG protein, mouse
0
Interleukin-17
0
Transforming Growth Factor beta
0
Interleukin-4
207137-56-2
Dexamethasone
7S5I7G3JQL
Interferon-gamma
82115-62-6
Ovalbumin
9006-59-1
carvacrol
9B1J4V995Q
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5343-5354Informations de copyright
© 2018 Wiley Periodicals, Inc.